InVitro International (IVRO)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -59.11 Thousand | 40.62 Thousand | 31.98 Thousand | -22.37 Thousand | 137.72 Thousand | 61.28 Thousand |
| Net Income | 1553.00 | 21.27 Thousand | 95.99 Thousand | 49.89 Thousand | 70.67 Thousand | 56.4 Thousand |
| Depreciation & Amortization | 3377.00 | 3892.00 | 2713.00 | 3585.00 | 9813.00 | 14.82 Thousand |
| Deferred income taxes | -68.27 Thousand | 48.28 Thousand | 37.38 Thousand | -71.8 Thousand | - | - |
| Stock-based compensation | 11.65 Thousand | 5256.00 | 9879.00 | 31.64 Thousand | - | 2450.00 |
| Change in working capital | -79.46 Thousand | 20.92 Thousand | 44.6 Thousand | -95.6 Thousand | 57.55 Thousand | -15.88 Thousand |
| Other non-cash items | 3771.00 | -53.75 Thousand | -148.71 Thousand | 91.51 Thousand | 24.31 Thousand | 40 Thousand |
| Investing Cash Flow | -816.37 Thousand | 685.3 Thousand | 12.07 Thousand | -35.71 Thousand | -87.05 Thousand | -205.61 Thousand |
| Investments in PPE | -850.00 | -9375.00 | -3096.00 | - | - | -520.00 |
| Acquisitions | - | -694.68 | -15.17 | - | - | - |
| Investment purchases | -815.52 Thousand | -98.61 Thousand | -482.28 Thousand | -289.44 Thousand | -340.78 Thousand | -270.77 Thousand |
| Sales/Maturities of investments | - | 793.28 Thousand | 497.45 Thousand | 253.72 Thousand | 253.72 Thousand | 65.67 Thousand |
| Other Investing Activities | -815.52 Thousand | 694.67 Thousand | 15.17 Thousand | -35.71 Thousand | -87.05 Thousand | -205.09 Thousand |
| Financing Cash Flow | - | -14.99 Thousand | 101.01 Thousand | 106.66 Thousand | -50.61 Thousand | - |
| Debt repayment | - | - | -101.01 Thousand | -106.66 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -14.99 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -15.00 | 101.01 Thousand | 106.66 Thousand | - | - |
| Accounts receivables | -45.17 Thousand | 70.81 Thousand | 24.34 Thousand | -46.65 Thousand | -13.55 Thousand | 6118.00 |
| Accounts payables | 2821.00 | 2395.00 | -6789.00 | -6516.00 | 28.64 Thousand | -4665.00 |
| Inventory | -5619.00 | -17.13 Thousand | 25.27 Thousand | -11.43 Thousand | -20.09 Thousand | -5872.00 |
| Other working capital | -28.67 Thousand | -35.15 Thousand | 1778.00 | -31 Thousand | 62.55 Thousand | -11.46 Thousand |
| Cash at beginning of period | 1.23 Million | 521.54 Thousand | 378.93 Thousand | 330.25 Thousand | 279.49 Thousand | 423.72 Thousand |
| Cash at end of period | 356.98 Thousand | 1.23 Million | 521.54 Thousand | 378.93 Thousand | 330.25 Thousand | 279.49 Thousand |
| Capital Expenditure | -850.00 | -9375.00 | -3096.00 | - | - | -520.00 |
| Effect of forex changes on cash | - | -710.21 Thousand | -2470.00 | 74.00 | 102.00 | 102.00 |
| Net cash flow / Change in cash | -875.48 Thousand | 710.92 Thousand | 142.6 Thousand | 48.68 Thousand | 50.76 Thousand | -144.23 Thousand |
| Free Cash Flow | -59.96 Thousand | 31.24 Thousand | 28.89 Thousand | -22.37 Thousand | 137.72 Thousand | 60.76 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 16.23 Thousand | 47.67 Thousand | 17.66 Thousand | 49.03 Thousand | 1553.00 | -13.16 Thousand |
| Depreciation & Amortization | 1507.00 | 1230.00 | 1091.00 | 1092.00 | 4327.00 | 1091.00 |
| Deferred income taxes | - | - | - | - | -68.27 Thousand | - |
| Stock-based compensation | - | - | - | - | 11.65 Thousand | - |
| Change in working capital | 3156.00 | -9189.00 | 23.38 Thousand | -54.04 Thousand | -76.64 Thousand | -31.25 Thousand |
| Other non-cash items | -583.00 | 17.87 Thousand | -13.92 Thousand | 34.44 Thousand | 68.27 Thousand | 40.13 Thousand |
| Investing Cash Flow | -9802.00 | -9667.00 | -9056.00 | -8378.00 | -816.37 Thousand | -305.73 Thousand |
| Investments in PPE | 2.00 | - | - | - | -850.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -9802.00 | -9667.00 | -9056.00 | -8378.00 | -815.52 Thousand | -305.73 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -815.52 Thousand | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 4774.00 | 5194.00 | 34.95 Thousand | -13.09 Thousand | -45.17 Thousand | -42.04 Thousand |
| Accounts payables | -3001.00 | -11.9 Thousand | 6911.00 | -10.57 Thousand | 2821.00 | 12.14 Thousand |
| Inventory | 3023.00 | -7511.00 | -21.2 Thousand | -5181.00 | -5619.00 | -5258.00 |
| Other working capital | -1640.00 | 5030.00 | 2721.00 | -25.19 Thousand | -28.67 Thousand | 3901.00 |
| Cash at beginning of period | 425.87 Thousand | 394.62 Thousand | 356.98 Thousand | 365.87 Thousand | 1.23 Million | 712.13 Thousand |
| Cash at end of period | 438.17 Thousand | 425.87 Thousand | 394.62 Thousand | 356.98 Thousand | 356.98 Thousand | 365.87 Thousand |
| Capital Expenditure | 2.00 | - | - | - | -850.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.29 Thousand | 31.25 Thousand | 37.63 Thousand | -8889.00 | -875.48 Thousand | -346.25 Thousand |
| Free Cash Flow | 22.1 Thousand | 40.91 Thousand | 46.69 Thousand | -511.00 | -59.96 Thousand | -40.52 Thousand |
600711
ELCRE
GRCAF
2931
SRDAPRT
GEFR